Pfizer | PFE

Stock Price
28.59
Daily Change
-0.26 -0.90%
Monthly
1.17%
Yearly
-26.86%
Q2 Forecast
28.52
Peers Price Chg Day Year Date
AbbVie 169.52 0.75 0.44% 23.16% Jun/07
Abbott 107.58 3.48 3.34% 6.75% Jun/07
ALKERMES 23.91 -0.25 -1.03% -24.19% Jun/07
Amgen 305.37 -0.48 -0.16% 38.32% Jun/07
AstraZeneca 12,556.00 -34.00 -0.27% 6.86% Jun/07
Bayer 28.09 -0.30 -1.04% -45.93% Jun/07
Biogen 225.58 -6.51 -2.80% -26.97% Jun/07
Bristol-Myers Squibb 41.41 0.62 1.52% -36.59% Jun/07
Catalent 56.40 0.22 0.39% 44.62% Jun/07
Gilead Sciences 64.70 0.82 1.28% -17.47% Jun/07
GlaxoSmithKline 1,629.00 -11.00 -0.67% 18.46% Jun/07
Glaxosmithkline 41.21 -0.33 -0.79% 18.69% Jun/07
J&J 147.06 0.69 0.47% -8.24% Jun/07
Eli Lilly 851.00 14.01 1.68% 90.95% Jun/07
Medtronic 84.07 1.67 2.03% 1.17% Jun/07
Merck 130.62 0.15 0.12% 18.40% Jun/07
Neurocrine Biosciences 134.97 1.90 1.43% 43.54% Jun/07
Novartis 94.95 -0.04 -0.04% 5.07% Jun/07
Novartis 105.37 -0.88 -0.83% 4.68% Jun/07
Prestige Brands 65.44 0.61 0.94% 12.34% Jun/07
Pacira 28.57 -0.55 -1.89% -22.80% Jun/07
Pfizer 28.59 -0.26 -0.90% -26.86% Jun/07
Perrigo 26.95 -0.07 -0.26% -19.93% Jun/07
Drreddys Laboratories 71.36 1.01 1.44% 25.21% Jun/07
Regeneron Pharmaceuticals 1,002.95 2.87 0.29% 33.71% Jun/07
Roche Holding 242.60 4.20 1.76% -14.56% Jun/07
Sanofi 91.13 0.12 0.13% -4.52% Jun/07
Sanofi 48.99 -0.60 -1.20% -4.95% Jun/07
Vertex Pharmaceuticals 483.05 -1.95 -0.40% 45.24% Jun/07
Zoetis 177.04 0.25 0.14% 7.75% Jun/07

Indexes Price Day Year Date
US500 5347 -5.97 -0.11% 24.52% Jun/07

Pfizer traded at $28.59 this Friday June 7th, decreasing $0.26 or 0.90 percent since the previous trading session. Looking back, over the last four weeks, Pfizer lost 1.17 percent. Over the last 12 months, its price fell by 26.86 percent. Looking ahead, we forecast Pfizer to be priced at 28.52 by the end of this quarter and at 28.01 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.